STVN | Stevanato Group S.p.A. Stock Overview

(Stock Exchange: NYSE)

Day's Range	20.21 - 21.50
52 Week Range	16.56 - 34.73
Beta	0.58
Implied Volatility	81.15%
IV Rank	82.53%
Day's Volume	436,547
Average Volume	510,758
Shares Outstanding	272,640,253
Market Cap	5,605,483,602
Sector	Healthcare
Industry	Medical - Instruments & Supplies
IPO Date	2021-07-16

Valuation
Profitability
Growth
Health
P/E Ratio	45.69
Forward P/E Ratio	N/A
EPS	0.45
1YR Price Target	N/A
Dividend Yield	0.26%
Dividend Per Share	0.05
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	5,635
Country	Italy
Website	STVN

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.

STVN's peers: RYAN, HAE, MMSI, ANGO, ATR, NVST, ICUI, COO, TFX, WST, ALC, RMD, XRAY, ATRC, AKYA

*Chart delayed

Analyzing fundamentals for STVN we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is bad and Health is very weak. For more detailed analysis please see STVN Fundamentals page.

Watching at STVN technicals we can see that long-term trend is bearish, while middle-term trend is bullish, but short-term trend is bearish. More technicals details can be found on STVN Technicals page.